RMD: ResMed Inc Price to Sales

Symbol and logo of brand ResMed Inc (RMD)

ResMed Inc. (RMD) integrates the production of lung ventilation systems with cloud services, reducing its dependence on price fluctuations. However, revenue stability relies on chip availability and insurance payouts. The price-to-sales ratio visualizes this trend, where 5.90 is recorded as the baseline value. Looking ahead, the impact of GLP-1 drugs remains merely a hypothetical risk to demand.

RMD (ResMed) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for ResMed Corp (RMD)

- market price and analyst price targets:
Stock Quotes resmed.com|RMD - Analyst Consensus Forecast
- market capitalization information:
Market Value ResMed Corp|RMD - Enterprise Value
- shareholders' equity book value data:
Equity per Share ResMed|RMD - Book Capitalization|Market Capitalization to Book Value resmed.com|RMD - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio ResMed Inc.|RMD - Long-Term Debt to Capital|Short-Term Debt to Capital ResMed Corporation|RMD - Company Debts|Debt to Book Capitalization Ratio ResMed Corp|RMD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings ResMed|Immediate Liquidity resmed.com
- net income and valuation multiples indicators:
RMD - Company Net Income|Projected Net Profit ResMed Inc.|RMD - Price to Earnings Ratio|Forward P/E Multiple ResMed Inc|RMD - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio ResMed Corp|RMD - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months ResMed|RMD - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months resmed.com|RMD - Earnings growth in current year|Expected net earnings per share growth next year ResMed Inc.
- issuer revenue and sales details:
RMD - Company Revenue|Company Revenue Forecast resmed.com|RMD - Market Cap to Revenue|Price to Expected Revenue Ratio ResMed Corp
Fundamental company analysis:resmed.com RMD
Original product of ResMed Corp

Steady demand for apnea therapy accessories provides ResMed Inc. (RMD) with a predictable cash flow, rendering its revenue a reliable foundation for business valuation. By analyzing the P/S chart, an investor determines the value of a single dollar of sales within the capitalization structure, identifying whether the asset is undervalued or if there is a risk of overpayment when the multiple deviates from its historical averages.

Who ResMed Inc. competes with

Market Cap to Revenue bostonscientific.com BSX|P/S Multiple EW (Edwards Lifesciences Corporation)|Insulet Corp (PODD) - Price to Sales|Zimmer - P/S Multiple|COO (CooperSurgical) - Market Cap to Revenue Ratio|ALGN: P/S Multiple|GMED - Price-to-Revenue Coefficient|TMDX (TransMedics Group, Inc.) - P/S Multiple|Market Cap to Revenue Alphatec Holdings (ATEC)|P/S Multiple AORT|P/S Multiple Enovis Inc. (ENOV)|Price-to-Revenue Ratio Integra LifeSciences IART|establishmentlabs.com - Price-to-Revenue Ratio|BBNX: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio IRMD (IRADIMED Corp)|EMBC: P/S Multiple|Price to Sales Tandem Corp (TNDM)|Price-to-Revenue Ratio AxoGen, Inc.|SIBN - Price-to-Revenue Multiple|Market Cap to Revenue OFIX (Orthofix)|P/S Multiple Bioventus Inc (BVS)|P/S Multiple KIDS (OrthoPediatrics)|Price-to-Revenue Coefficient Treace Corp (TMCI)|SRTA - Price-to-Revenue Ratio|Price-to-Sales Ratio CARL|RxSight (RXST) - Price-to-Revenue Ratio|Market Cap to Revenue ClearPoint Neuro|STXS (Stereotaxis Corp) - P/S Multiple|Price to Sales Neuronetics, Inc STIM|Price-to-Revenue Ratio Sight Sciences, Inc. (SGHT)|orchestrabiomed.com - Market Cap to Revenue Ratio|Anika Therapeutics, Inc. - Market Cap to Revenue|Market Cap to Sales Volume NSPR (InspireMD Inc)|ZJYL - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio VANI (Vivani Medical, Inc.)|XTNT: P/S Multiple|Price to Sales n1mtc.com (NMTC)|Price-to-Revenue Ratio Modular Medical Inc|Myomo Inc. (MYO) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Envoy Medical, Inc (COCH)|Market Cap to Revenue Vivos Therapeutics Inc VVOS|P/S Multiple NVNO (enVVeno Medical)|Sintx Technologies Inc (SINT) - Price to Sales|Tenon Medical - P/S Multiple|LFWD (ReWalk Robotics) - Market Cap to Revenue Ratio|AMIX (autonomix.com) - Market Cap to Revenue|INVO Fertility Corp - Market Capitalization-to-Revenue Ratio|BBLG (Bone Biologics) - P/S Multiple|axonics.com (AXNX) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio BIOLASE (BIOL)|dynatronics.com - Market Cap to Revenue Ratio|P/S Multiple FNA (Paragon 28)|INVO - Market Cap to Revenue